The National Cancer Institute is offering a grant to support research on the etiology, prevention, and treatment of hepatocellular carcinoma (HCC). Projects should focus on understanding HCC mechanisms, developing animal models, prevention strategies, diagnostic tools, and therapeutic approaches. This Funding Opportunity Announcement (FOA) requires at least three component projects sharing a common theme. Applications exclusively focused on population studies will not be supported. The grant will be awarded through the NIH Program Project (P01) mechanism, with funding contingent on availability and merit. Applicants must submit their proposals by April 8, 2009, 12:00 AM EDT.
Opportunity ID: 43561
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-08-245 |
| Funding Opportunity Title: | Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Dec 03, 2008 |
| Last Updated Date: | Apr 08, 2009 |
| Original Closing Date for Applications: | May 31, 2011 |
| Current Closing Date for Applications: | Apr 08, 2009 |
| Archive Date: | May 08, 2009 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education State governments For profit organizations other than small businesses Small businesses Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Regional Organizations; U.S. Territory or Possession; Units of Local Governments Whereas Foreign institutions are not eligible to apply, they can be involved in Program Projects proposed by eligible Domestic institutions under subcontractual arrangements, if appropriate. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | -Purpose. With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI), invites grant applications that: (a) address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC); (b) propose development of animal models for HCC; (c) propose novel approaches to prevent HCC malignancy; (d) propose therapeutic or diagnostic tools for reliable prognostic indicators for HCC; and/or (e) develop therapeutic approaches to minimize morbidity and mortality associated with HCC in humans. The primary focus of the proposed projects must be on the basic biology, prevention, and/or treatment of liver cancer. Applications that are exclusively focused on population studies and epidemiology will not be supported in connection with this FOA.-Mechanism of Support. This FOA will utilize the NIH Program Project (P01) grant mechanism. Each Program Project application must consist of at least three component projects. The component projects must share a common central theme, focus, and/or overall objective.This FOA runs in parallel with two other FOA of similar scientific scope: PA-08-243 and PA-08-244, which encourage applications under the R01 and R21 grant mechanisms, respectively. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-08-245.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| This funding opportunity is being closed and archived, and has been reissued as PAR-09-147. | Apr 08, 2009 | |
| Apr 08, 2009 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-08-245 |
| Funding Opportunity Title: | Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Dec 03, 2008 |
| Last Updated Date: | Apr 08, 2009 |
| Original Closing Date for Applications: | May 31, 2011 |
| Current Closing Date for Applications: | Apr 08, 2009 |
| Archive Date: | May 08, 2009 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education State governments For profit organizations other than small businesses Small businesses Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Regional Organizations; U.S. Territory or Possession; Units of Local Governments Whereas Foreign institutions are not eligible to apply, they can be involved in Program Projects proposed by eligible Domestic institutions under subcontractual arrangements, if appropriate. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | -Purpose. With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI), invites grant applications that: (a) address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC); (b) propose development of animal models for HCC; (c) propose novel approaches to prevent HCC malignancy; (d) propose therapeutic or diagnostic tools for reliable prognostic indicators for HCC; and/or (e) develop therapeutic approaches to minimize morbidity and mortality associated with HCC in humans. The primary focus of the proposed projects must be on the basic biology, prevention, and/or treatment of liver cancer. Applications that are exclusively focused on population studies and epidemiology will not be supported in connection with this FOA.-Mechanism of Support. This FOA will utilize the NIH Program Project (P01) grant mechanism. Each Program Project application must consist of at least three component projects. The component projects must share a common central theme, focus, and/or overall objective.This FOA runs in parallel with two other FOA of similar scientific scope: PA-08-243 and PA-08-244, which encourage applications under the R01 and R21 grant mechanisms, respectively. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-08-245.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-08-245 |
| Funding Opportunity Title: | Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 08, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 31, 2011 |
| Archive Date: | Jul 01, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Regional Organizations; U.S. Territory or Possession; Units of Local Governments Whereas Foreign institutions are not eligible to apply, they can be involved in Program Projects proposed by eligible Domestic institutions under subcontractual arrangements, if appropriate. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | -Purpose. With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI), invites grant applications that: (a) address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC); (b) propose development of animal models for HCC; (c) propose novel approaches to prevent HCC malignancy; (d) propose therapeutic or diagnostic tools for reliable prognostic indicators for HCC; and/or (e) develop therapeutic approaches to minimize morbidity and mortality associated with HCC in humans. The primary focus of the proposed projects must be on the basic biology, prevention, and/or treatment of liver cancer. Applications that are exclusively focused on population studies and epidemiology will not be supported in connection with this FOA. -Mechanism of Support. This FOA will utilize the NIH Program Project (P01) grant mechanism. Each Program Project application must consist of at least three component projects. The component projects must share a common central theme, focus, and/or overall objective.This FOA runs in parallel with two other FOA of similar scientific scope: PA-08-243 and PA-08-244, which encourage applications under the R01 and R21 grant mechanisms, respectively. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-08-245.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
There are no packages on this grant.
Leave a Reply